M Kathleen Behrens Igm Biosciences, Inc. (IGMS) insider trading activity

M Kathleen Behrens is of IGM Biosciences, Inc.. Currently has a direct ownership of 22,222 shares of IGMS, which is worth approximately $28,221. The most recent transaction as insider was on Jun 30, 2025, when has been sold 1,471 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.2K

7.09% 3M change

69.32% 12M change

Total Value Held $28,221

M KATHLEEN BEHRENS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2025	BUY Grant, award, or other acquisition	-	1,471 Added 6.21%	22,222 Common Stock
Mar 31 2025	BUY Grant, award, or other acquisition	-	1,471 Added 6.62%	20,751 Common Stock
Dec 31 2024	BUY Grant, award, or other acquisition	-	3,078 Added 13.77%	19,280 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	-	3,078 Added 15.96%	16,202 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	-	3,078 Added 19.0%	13,124 Common Stock
Mar 29 2024	BUY Grant, award, or other acquisition	-	3,078 Added 23.45%	10,046 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	-	800 Added 10.3%	6,968 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	-	800 Added 11.48%	6,168 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	800 Added 12.97%	5,368 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	800 Added 14.9%	4,568 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	-	374 Added 9.03%	3,768 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	374 Added 9.93%	3,394 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	374 Added 11.02%	3,020 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	374 Added 12.38%	2,646 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	-	211 Added 8.5%	2,272 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	211 Added 9.29%	2,061 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	211 Added 10.24%	1,850 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	211 Added 0.22%	94,139 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	-	357 Added 0.38%	93,928 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	-	357 Added 0.38%	93,571 Common Stock

Also insider at

MDXG

MIMEDX GROUP, INC. Healthcare

Director

SRPT

Sarepta Therapeutics, Inc. Healthcare

MKB